Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Analysis of the experience of Professor ZHANG Zhilong using Yunpi Xiezhuo Recipe in the treatment of hyperuricemia
Hits 657  Download times 379  Received:November 10, 2021  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2022.02.04
Key Words   hyperuricemia;Yunpi Xiezhuo Recipe;ZHANG Zhilong
Author NameAffiliation
WANG Man Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China 
DING Yajie Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China 
Abstract
    Professor ZHANG Zhilong's syndrome differentiation and treatment of hyperuricemia is based on the analysis of the cause of the syndrome. The diagnosis and treatment of hyperuricemia are blamed on the spleen. The law is unconventional, and both spleen deficiency and turbidity are the core pathogenesis of hyperuricemia, wet, stasis, turbidity, and poison are susceptible factors and the pathological product of hyperuricemia. He proposed that yunpi xiezhuo is the fundamental method for the treatment of hyperuricemia, and raised the Yunpi Xiezhuo Recipe. The prescription contains both supplement and reducing methods, uses both moistening and drying drugs, controls both elevating and descending condition, supplements the middle jiao deficiency, regulates qi stagnation, unblocks the passage, cleans the dampness evil, excretes the turbid stasis, which prevents dampness evil blocking middle zhou transportation and give the turbid poison in upper zhou way out, leading turbid stasis cleaned, the function of spleen recovery, so that the elevated uric acid can be normalized. The clinical effect is satisfactory which provides new ideas and methods for the treatment of hyperuricemia.

You are the 2311740 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.